Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review.
Ann Med Surg (Lond)
; 73: 102988, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1487594
ABSTRACT
The novel coronavirus pandemic has taken a toll on the global healthcare systems and economy. Safety precautions, along with vaccination, are the most effective preventive measures. The global vaccination program against COVID-19 has dramatically reduced the number of deaths and cases. However, the incidence of thrombotic events and thrombocytopenia post-COVID-19 vaccination known as vaccine-induced thrombotic thrombocytopenia has raised safety concerns. This has led to an element of vaccine hesitancy. The exact mechanism for vaccine-induced thrombotic thrombocytopenia is unknown. Although the incidence of thrombosis associated with COVID-19 vaccination is low, it still requires attention, especially in older people, smokers, and people with preexisting comorbidities. This study aims to review the pathophysiology, diagnosis, and management of vaccine-induced thrombotic thrombocytopenia, to provide a concise and comprehensive update.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Reviews
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Ann Med Surg (Lond)
Year:
2022
Document Type:
Article
Affiliation country:
J.amsu.2021.102988
Similar
MEDLINE
...
LILACS
LIS